| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 08/18/2004 | EP0817851B9 Dna encoding human papilloma virus type 18 |
| 08/18/2004 | EP0805870A4 Spectroscopically detectable nucleic acid ligands |
| 08/18/2004 | EP0804587B1 Mutant luciferases |
| 08/18/2004 | EP0783366B1 Chromatographic resins and methods for using same |
| 08/18/2004 | EP0471011B2 HUMAN LACTOFERRIN cDNA SEQUENCE |
| 08/18/2004 | CN1522305A Amplification process |
| 08/18/2004 | CN1522298A Method of stabilizing alkaline phosphatase |
| 08/18/2004 | CN1522235A Process for the preparation of amorphous cilastatin sodium |
| 08/18/2004 | CN1521257A Microencapsulated cell of human tissue kallikrein, microencapsulating method and application thereof |
| 08/18/2004 | CN1521181A L- sorbose dehydrogenase gene and its coding protein |
| 08/18/2004 | CN1521180A Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 08/18/2004 | CN1162545C Cathepsin B gene of Helicoverpa armigera and its cloning, recombining and expressing technique |
| 08/18/2004 | CN1162544C 基因 Gene |
| 08/18/2004 | CN1162543C Gene encoding sulfotransferase |
| 08/18/2004 | CN1162540C Alcohol/aldehyde dehydrogenase |
| 08/17/2004 | US6777590 Nucleotide sequences for use in the propagation of agricultural crops |
| 08/17/2004 | US6777587 Method of enhancing plant resistance to geminiviruses by transformation with a SNF-1 polynucleotide |
| 08/17/2004 | US6777546 Expression vector for use in the treatment of defects of immunological response |
| 08/17/2004 | US6777545 Human kinases and polynucleotides encoding the same |
| 08/17/2004 | US6777443 For therapy of cardiovascular disorders in mammals; for inhibiting both angiotensin converting enzyme and neutral endopeptidase in mammals |
| 08/17/2004 | US6777403 Method and structure for inhibiting activity of serine elastases |
| 08/17/2004 | US6777390 Stable blood coagulation inhibitor-free factor vii preparation and method for preparing same |
| 08/17/2004 | US6777221 Can be used for diagnosis, drug screening, clinical trial monitoring and therapy of physiological disorders |
| 08/17/2004 | US6777218 Subtilase enzymes having an improved wash performance on egg stains |
| 08/17/2004 | US6777217 Genes which are involved in the control of chromatin structure and, thus in transcription and translation; used to control cell proliferation and differentiation in vitro and in vivo |
| 08/17/2004 | US6777216 Ethanolaminephosphate cytidylytransferase gene and promoter |
| 08/17/2004 | US6777215 Enzymatic polypeptides for use in starch degradation, food preparation and cosmetics |
| 08/17/2004 | US6777210 Method and reagents for inactivating ribonucleases RNase A, RNase I and RNase T1 |
| 08/17/2004 | US6777209 Vectors, cells and processes for pyrimidine deoxyribonucleosides production |
| 08/17/2004 | US6777203 Telomerase promoter driving expression of therapeutic gene sequences |
| 08/17/2004 | US6777202 Process for the recombinant production of s-layer proteins in gram-negative host cells |
| 08/17/2004 | US6777190 Immunoassays for the detection of selected analytes in a fluid sample |
| 08/17/2004 | US6777188 Determining the genotype of diploid organism; obtain alleles of target genes, incubate with primers, amplify, detect signal, classify hybridization pattern |
| 08/17/2004 | US6777179 Drug screening for an antiviral agent, viricides; genetic engineering |
| 08/17/2004 | CA2325228C Catalytic domain of the human effector cell cycle checkpoint protein kinase, chk1, materials and methods for identification of inhibitors thereof |
| 08/17/2004 | CA2295861C Method of preparing a transgenic non-human animal expressing p25 |
| 08/12/2004 | WO2004068109A2 Autologous or homologous coagulant produced from anticoagulated whole blood |
| 08/12/2004 | WO2004067773A1 Screening assay based on rhe sod-3 promotor for the identification of compounds modulating akt or upstream regulators such as insulin/igf-1 receptors |
| 08/12/2004 | WO2004067768A2 Improved method for the detection of proteolytic enzymes |
| 08/12/2004 | WO2004067760A2 Xylose-fermenting recombinant yeast strains |
| 08/12/2004 | WO2004067753A2 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof. |
| 08/12/2004 | WO2004067739A2 Stabilization of granules |
| 08/12/2004 | WO2004067738A2 Nitrile hydratases from rhodococcus erythropolis and their application |
| 08/12/2004 | WO2004067737A2 Subtilases |
| 08/12/2004 | WO2004067736A2 Custom-made meganuclease and use thereof |
| 08/12/2004 | WO2004067722A2 Facls as modifiers of the rb pathway and methods of use |
| 08/12/2004 | WO2004067721A2 Tkts as modifiers of the beta-catenin pathway and methods of use |
| 08/12/2004 | WO2004067705A2 Stable lipase variants |
| 08/12/2004 | WO2004067557A1 Methods for refining concentrated enzyme solutions |
| 08/12/2004 | WO2004067548A2 Chemically modified metabolites of regulatory peptides and methods of producing and using same |
| 08/12/2004 | WO2004067542A1 Oligosaccharide derivative |
| 08/12/2004 | WO2004066945A2 Enzymes and the nucleic acids encoding them and methods for making and using them |
| 08/12/2004 | WO2004066921A2 Erbb4 co-crystal |
| 08/12/2004 | WO2004066724A1 Transgenic animal having fatty acid desaturase and method of producing the same |
| 08/12/2004 | WO2004056988A3 Galactanase variants |
| 08/12/2004 | WO2004056967A3 Generation of plants with altered oil content |
| 08/12/2004 | WO2004056858A3 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders |
| 08/12/2004 | WO2004056384A3 Use of factor vii polypeptides for preventing formation of inhibitors to blood coagulation factor viii and ix |
| 08/12/2004 | WO2004054969A3 Sacromastigophoric therapeutic agent delivery system |
| 08/12/2004 | WO2004039845A8 Antimicrobial lipase antibodies their nucleotide and aminoacid sequences and uses thereof |
| 08/12/2004 | WO2004033691A3 Human lipid phosphate phosphatases and uses thereof for treating neuronal diseases |
| 08/12/2004 | WO2004032880A3 Method for inhibiting angiogenesis with ship-1 inhibitors |
| 08/12/2004 | WO2004001000A3 Intron double stranded rna constructs and uses thereof |
| 08/12/2004 | WO2003079977A3 Novel compositions and methods in cancer associated with altered expression of mcm3ap |
| 08/12/2004 | WO2003066804A3 Thermus scotoductus nucleic acid polymerases |
| 08/12/2004 | WO2003054217A3 Plant msh2 sequences and methods of use |
| 08/12/2004 | WO2003042693A3 Method for measuring intracellular atp and/or gene expression |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | WO2003023028A9 Fungal glyoxal oxidases |
| 08/12/2004 | WO2002077179A8 Leinamycin biosynthesis gene cluster and its components and their uses |
| 08/12/2004 | WO2002057408A3 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 08/12/2004 | WO2002040997A3 Production and use of proteins producing an altered immunogenic response |
| 08/12/2004 | US20040158891 Comprises nucleotide sequences coding senescence induced hydrolase in antisense orientation for generating plants with prolonged life or shelf life, flowering, reduced fruit spoilage, seed aging and/or reduced yellowing of leaves |
| 08/12/2004 | US20040158890 Sequences encoding PhzO and methods |
| 08/12/2004 | US20040158881 Animal selected for lacking heparan sulfate 3-0-sulfotransferase-1 and uses thereof |
| 08/12/2004 | US20040158061 Reaction of (di)amines in the presence of a lysine oxidase and of a reducing agent |
| 08/12/2004 | US20040158045 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 08/12/2004 | US20040158043 Canine CYP1A2 sequences |
| 08/12/2004 | US20040157991 Method for the preparation of 1-benzotriazolyl carbonate esters of poly (ethylene glycol) |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157828 Protease inhibitors |
| 08/12/2004 | US20040157775 Effector proteins of rapamycin |
| 08/12/2004 | US20040157313 Ammonia-oxidizing bacteria |
| 08/12/2004 | US20040157310 Methods for enhancing the production of viral vaccines in cell culture |
| 08/12/2004 | US20040157309 for treating respiratory disorders; for producing a catalytic domain of a zinc metalloprotease; genetic engineering |
| 08/12/2004 | US20040157308 Alpha-galactosidase as food-grade genetic marker |
| 08/12/2004 | US20040157306 Mammalian protein phosphatases |
| 08/12/2004 | US20040157305 obtained from Rhodococcus; biocatalyst; stereospecific alcohol dehydrogenase activity in the oxidation of secondary alcohols or the reduction of ketones |
| 08/12/2004 | US20040157304 Molecular rotary nanomotor and methods of use |
| 08/12/2004 | US20040157302 exhibiting inhibitory activity against lanosterol synthase for preventive and therapeutic agents caused by accumulation of cholesterol in humans and antifungal agents; using streptomyces |
| 08/12/2004 | US20040157297 for drug screening anticancer agents using animal models; biochips; genetic engineering |
| 08/12/2004 | US20040157286 Process for producing coenzymes q10 |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157249 Canine L-PBE sequences |
| 08/12/2004 | US20040157248 With a deletion of at least 13-20 amino acids residues from the carboxyl terminus; highly proficient in both the ssDNA binding protein from E. coli, SSB displacement and steady state binding of DNA in the presence or absence of SSB as compared to the wild-type protein; increasing recombination efficiency |
| 08/12/2004 | US20040157246 Purified protein encoded by a nucleic acid hybridizable to a DNA of given sequence; use in diagnosis, prognosis and screening for a disposition to cardiovascular disorders |
| 08/12/2004 | US20040157241 Haemophilus adherence and penetration proteins |
| 08/12/2004 | US20040157239 Endonuclease capable of cleaving DNA from divalent cations, which retains its activity in acidic to neutral pH range, and is not inhibited by G-actin; treatment of cystic fibrosis |
| 08/12/2004 | US20040157234 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, BGS42 |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |